Nobiastx
1 known investors
Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.
Founders & leadership
HH
Hakon HakonarsonCo-Founder and Chief Scientific Advisor
BH
Brian HalakCo-Founder
PD
Patrick DoughertyChief Executive Officer
RM
Ryan McMillianConsulting Chief Financial Officer
Investors · 1
Competitors · 2
by search overlapNorthwest Biotherapeutics5 shared keywordsNorthwest Biotherapeutics is a clinical-stage biotechnology company developing personalized cancer vaccines, marketed under the DCVax platform, that use activated dendritic cells to treat a range of solid tumor cancers. Its product lines include DCVax-L, DCVax-Direct, and DCVax-Prostate.
Nosis Bio3 shared keywordsNosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
Companies competing with Nobiastx for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Nobiastx do?
- Nobias Therapeutics is a clinical-stage drug developer creating small-molecule therapeutics for genetically-defined rare diseases, initially focused on pediatric indications with potential expansion into adult and non-rare conditions. It uses genomic and health datasets alongside relationships with pediatric academic medical centers across North America to advance drug discovery.
- Who founded Nobiastx?
- Nobiastx was founded by Hakon Hakonarson, Brian Halak.
- Who are Nobiastx's investors?
- Nobiastx's investors include Medical Excellence Capital.